Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

Alexandra Sch?nherr; Viktoria Aivazova-Fuchs; Katja Annecke; Julia Jückstock; Philip Hepp; Ulrich Andergassen; Doris Augustin; Wolfgang Simon; Arthur Wischnik; Svjetlana Mohrmann; Jessica Salmen; Thomas Zwingers; Marion Kiechle; Nadja Harbeck; Klaus Friese; Wolfgang Janni; Brigitte Rack

首页> 外文期刊>Breast care >Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

【24h】

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉类序贯疗法与FEC120的比较对高危乳腺癌的辅助治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Data from meta-analyses have shown taxane-containing therapies to be superior to anthracycline-based treatments for high-risk breast cancer.

机译：荟萃分析的数据表明，含紫杉烷类药物的治疗优于基于蒽环类药物的高危乳腺癌治疗。

著录项

来源
《Breast care》 |2012年第4期|共页
作者
Alexandra Sch?nherr; Viktoria Aivazova-Fuchs; Katja Annecke; Julia Jückstock; Philip Hepp; Ulrich Andergassen; Doris Augustin; Wolfgang Simon; Arthur Wischnik; Svjetlana Mohrmann; Jessica Salmen; Thomas Zwingers; Marion Kiechle; Nadja Harbeck; Klaus Friese; Wolfgang Janni; Brigitte Rack;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Toxicity analysis in the ADEBAR trial: Sequential anthracycline-taxane therapy compared with FEC120 for the adjuvant treatment of high-risk breast cancer [J] . Sch?nherrA., Aivazova-FuchsV., AnneckeK., Breast care . 2012,第4期

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉烷类序贯治疗与FEC120的比较对高危乳腺癌的辅助治疗
2. Acute toxicity of intensity-modulated radiotherapy with simultaneous integrated boost compared to 3D-conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer - interim results from a randomized controlled trial [J] . Krug D., Koeder C., Haefner M. F., Strahlentherapie und Onkologie . 2016,第Suppla1期

机译：强度调节放疗的急性毒性与乳腺癌辅助治疗中的3D-on成形放疗相比同时集成升压与乳腺癌的佐剂治疗 - 来自随机对照试验的中期结果
3. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial [J] . Martin Eichler, Susanne Singer, Wolfgang Janni, Breast cancer . 2017,第2期

机译：高危乳腺癌接受化疗的患者的治疗前生活质量，表现状态及其与治疗中止和治疗变化的关系：前瞻性随机ADEBAR试验结果
4. Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials [C] . F. Boccardo, A. Rubagotti, D. Amoroso, International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：意大利乳腺癌辅助化疗化学 - 激素治疗合作团体试验
5. The Use and Enhancement of Anti-Cancer Vaccine Therapy with Low-Toxicity Drugs for the Treatment of HER2 Positive Breast Cancer [D] . Oechsle, Crystal Mae 2019

机译：低毒药物抗癌疫苗治疗在HER2阳性乳腺癌治疗中的应用和增强
6. Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer [O] . Alexandra Schönherr, Viktoria Aivazova-Fuchs, Katja Annecke, 2012

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉类序贯疗法与FEC120的比较对高危乳腺癌的辅助治疗
7. Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer [O] . S. Karger Gmbh, Ulrich Andergassend, Svjetlana Mohrmanna, 2015

机译：aDEBaR试验中的毒性分析：顺序蒽环类 - 紫杉烷治疗与FEC120治疗高风险乳腺癌的辅助治疗比较

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅